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The rapid evolution of the influenza A virus poses a global
challenge to public health. Recent events, such as the
spread of highly pathogenic H5N1 influenza virus, have
heightened concerns of potential pandemics. Thus, there
is an urgent need for a better understanding of influenza
virus evolution. Due to the development of high-through-
put sequencing technologies, large-scale sequencing of
influenza viruses has become routine work in influenza
surveillance, and analyses of these large-scale viral
sequence data have significantly enhanced our under-
standing of influenza evolution. However, opportunities
remain to extract even more useful information to inform
influenza prevention and control strategy. As we know,
seasonal influenza prevention and control rely largely on
the availability of effective vaccines. However, timely and
accurate recommendation of vaccine strains is quite chal-
lenging, as evidenced by frequent antigenic mismatches
between the recommended vaccine strains and circulating
strains.
Our recent work has shown that development of
sequence-based computational approaches to modeling
the antigenic evolution of the influenza virus holds great
promise for more effective vaccine strain recommendation
[1,2]. Based on whole-genome information, we have devel-
oped a network model to represent each H3N2 virus as a
nucleotide-co-occurrence network [1]. The network
model effectively captures the evolutionary antigenic fea-
tures of H3N2 virus at the whole-genome level and accu-
rately describes the complex evolutionary patterns
between individual gene segments. Our analyses show that
the co-occurring nucleotide modules apparently underpin
the dynamics of human H3N2 evolution, and that amino
acid substitutions corresponding to nucleotide co-changes
cluster preferentially in known antigenic regions of the
viral surface protein hemagglutinin (HA). Therefore, our
study demonstrates that nucleotide co-occurrence net-
works represent a powerful method for tracking influenza
A virus evolution, and that cooperative genomic interac-
tion is a major force underlying influenza virus evolution.
Based on the sequences of HA, the major antigen of influ-
enza virus, we have developed a computational method,
denoted as PREDAC, to predict antigenic clusters of influ-
enza A (H3N2) viruses with high accuracy from viral HA
sequences [2]. Application of PREDAC to large-scale HA
sequence data from H3N2 viruses isolated from diverse
regions of mainland China identified 17 antigenic clusters
that have dominated for at least one season between 1968
and 2010. By tracking the dynamics of the dominant anti-
genic clusters, we not only find that dominant antigenic
clusters change more frequently in China than in the Uni-
ted States and Europe, but also characterize the antigenic
patterns of seasonal H3N2 viruses within China. Further-
more, we demonstrate that the coupling of large-scale HA
sequencing with PREDAC can significantly improve vac-
cine strain recommendation for China.
Published: 1 October 2012
References
1. Du X, Wang Z, Wu A, Song L, Cao Y, Hang H, Jiang T: Networks of
genomic co-occurrence capture characteristics of human influenza A
(H3N2) evolution. Genome Res 2008, 18:178-87.
2. Du X, Dong L, Lan Y, Peng Y, Wu A, Zhang Y, Huang W, Wang D, Wang M,
Guo Y, Shu Y, Jiang T: Mapping of H3N2 influenza antigenic evolution in
China reveals a strategy to facilitate vaccine strain recommendation. Nat
Commun 2012, 3, doi:10.1038/ncomms171.
doi:10.1186/1753-6561-6-S6-P44
Cite this article as: Jiang: Modeling influenza sequence evolution for
vaccination. BMC Proceedings 2012 6(Suppl 6):P44.
Institute of Biophysics, Chinese Academy of Sciences, Beijing, China
Jiang BMC Proceedings 2012, 6(Suppl 6):P44
http://www.biomedcentral.com/1753-6561/6/S6/P44
© 2012 Jiang; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in
any medium, provided the original work is properly cited.
